GE-8820

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameGE-8820
Drug Alias NameGE8820GE-8820
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionAsialoglycoprotein receptor bindersImmunoglobulin G degraders
TargetsImmunoglobulin GAsialoglycoprotein receptor
Therapy Area/IndicationsAutoimmune DiseasesPemphigusGlomerulonephritis, Membranous +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlycoera Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlycoera Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesPemphigusGlomerulonephritis, Membranous +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A